In stent restenosis is the major disadvantage of percutaneous transluminal angioplasty. To overcome this limitation, drug eluting stents were introduced. We have developed novel sirolimus eluting stent using biocompatible and biodegradable polymer matrix. Developed stent have biphasic release profile for sirolimus from a single layer of polymer matrix, having blend of slow and fast degrading polymers. Coating integrity of coated stents were evaluated after crimping and postexpansion with the help of scanning electron microscopy while thickness of coated stent was measured using destructive test method. This shows that drug-polymers bilayer was uniformly coated with the average thickness of 5.2 μms. There was no deformation after crimping and expansion of the stent. We have also measured in vitro and in vivo release profiles of sirolimus from stents which shows biphasic release characteristics, i.e., initial burst period followed by sustained release. In vitro release profile is well correlated with in vivo release in blood and arterial tissues. Developed stents showed good efficacy and safety in porcine coronary artery model.

References

References
1.
Garcia-Garcia
,
H. M.
,
Vaina
,
S.
,
Tsuchida
,
K.
, and
Serruys
,
P. W.
,
2006
, “
Drug-Eluting Stents
,”
Arch. Inst. Cardiol. Mex
,
76
(
3
), pp.
297
319
.
2.
Daemen
,
J.
, and
Serruys
,
P. W.
,
2007
, “
Drug-Eluting Stent Update 2007—Part I: A Survey of Current and Future Generation Drug-Eluting Stents: Meaningful Advances or More of the Same?
,”
Circulation
,
116
(
3
), pp.
316
328
.10.1161/CIRCULATIONAHA.106.621342
3.
Venkatraman
,
S.
, and
Boey
,
F.
,
2007
, “
Release Profiles in Drug-Eluting Stents: Issues and Uncertainties
,”
J. Controlled Release
,
120
(
3
), pp.
149
160
.10.1016/j.jconrel.2007.04.022
4.
Kukreja
,
N.
,
Onuma
,
Y.
,
Daemen
,
J.
, and
Serruys
,
P. W.
,
2008
, “
The Future of Drug-Eluting Stents
,”
Pharmacol. Res.
,
57
(
3
), pp.
171
180
.10.1016/j.phrs.2008.01.012
5.
Tsuji
,
T.
,
Tamai
,
H.
,
Igaki
,
K.
,
Kyo
,
E.
,
Kosuga
,
K.
,
Hata
,
T.
,
Nakamura
,
T.
,
Fujita
,
S.
,
Tekeda
,
S.
,
Motohara
,
S.
, and
Uehata
,
H.
,
2003
, “
Biodegradable Stents as a Platform to Drug Loading
,”
Cardiovasc. Intervent Radiol.,
5
(
1
), pp.
13
16
.10.1080/14628840304609
6.
Dani
,
S.
,
Kukreja
,
N.
,
Parikh
,
P.
,
Joshi
,
H.
,
Prajapati
,
J.
,
Jain
,
S.
,
Thanvi
,
S.
,
Shah
,
B.
, and
Dutta
,
J.-P.
,
2008
, “
Biodegradable-Polymer-Based, Sirolimus-Eluting Supralimus Stent: 6-Month Angiographic and 30-Month Clinical Follow-Up Results From the Series I Prospective Study
,”
EuroIntervention
,
4
(
1
), pp.
59
63
.10.4244/EIJV4I1A11
7.
Han
,
Y.
,
Jing
,
Q.
,
Xu
,
B.
,
Yang
,
L.
,
Liu
,
H.
,
Shang
,
X.
,
Jiang
,
T.
,
Li
,
Z.
,
Zhang
,
H.
,
Li
,
H.
,
Qiu
,
J.
,
Liu
,
Y.
,
Li
,
Y.
,
Chen
,
X.
, and
Gao
,
R.
,
2009
, “
Safety and Efficacy of Biodegradable Polymer-Coated Sirolimus-Eluting Stents in “Real-World” Practice: 18-Month Clinical and 9-Month Angiographic Outcomes
,”
JACC: Cardiovasc. Intervent.
,
2
(
4
), pp.
303
309
.10.1016/j.jcin.2008.12.013
8.
Higgins
,
S. C.
,
Montgomery
,
G. H.
,
Raptis
,
G.
, and
Bovbjerg
,
D. H.
,
2008
, “
Effect of Pretreatment Distress on Daily Fatigue After Chemotherapy for Breast Cancer
,”
J. Oncol. Pract.
,
4
(
2
), pp.
59
63
.10.1200/JOP.0822002
9.
Peng
,
H. Y.
,
Chen
,
M.
,
Zheng
,
B.
,
Wang
,
X. G.
, and
Huo
Y.
,
2009
, “
Long-Term Effects of Novel Biodegradable, Polymer-Coated, Sirolimus-Eluting Stents on Neointimal Formation in a Porcine Coronary Model
,”
Int. Heart J.
,
50
(
6
), pp.
811
822
.10.1536/ihj.50.811
10.
Lao
,
L. L.
,
Venkatraman
,
S. S.
, and
Peppas
,
N. A.
,
2008
, “
Modeling of Drug Release From Biodegradable Polymer Blends
,”
Eur. J. Pharm. Biopharm.
,
70
(
3
), pp.
796
803
.10.1016/j.ejpb.2008.05.024
11.
Finkelstein
,
A.
,
McClean
,
D.
,
Kar
,
S.
,
Takizawa
,
K.
,
Varghese
,
K.
,
Baek
,
N.
,
Park
,
K.
,
Fishbein
,
M. C.
,
Makkar
,
R.
,
Litvack
,
F.
, and
Eigler
,
N. L.
,
2003
, “
Local Drug Delivery Via a Coronary Stent With Programmable Release Pharmacokinetics
,”
Circulation
,
107
(
5
), pp.
777
784
.10.1161/01.CIR.0000050367.65079.71
12.
Balakrishnan
,
B.
,
Dooley
,
J. F.
,
Kopia
,
G.
, and
Edelman
,
E. R.
,
2007
, “
Intravascular Drug Release Kinetics Dictate Arterial Drug Deposition, Retention, and Distribution
,”
J. Control Release
,
123
(
2
), pp.
100
108
.10.1016/j.jconrel.2007.06.025
13.
Guo
,
Q.
,
Knight
,
P. T.
, and
Mather
,
P. T.
,
2009
, “
Tailored Drug Release From Biodegradable Stent Coatings Based on Hybrid Polyurethanes
,”
J. Control Release
,
137
(
3
), pp.
224
233
.10.1016/j.jconrel.2009.04.016
14.
Tesfamariam
,
B.
,
2008
, “
Drug Release Kinetics From Stent Device-Based Delivery Systems
,”
J. Cardiovasc. Pharmacol.
,
51
(
2
), pp.
118
125
.10.1097/FJC.0b013e318158540f
15.
Rensing
,
B. J.
,
Vos
,
J.
,
Smits
,
P. C.
,
Foley
,
D. P.
,
Van den Brand
,
M. J. B. M.
,
van der Giessen
W. J.
,
de Feijter
,
P. J.
, and
Serruys
,
P. W.
,
2001
, “
Coronary Restenosis Elimination With a Sirolimus Eluting Stent
,”
Eur. Heart. J.
,
22
, pp.
2125
2130
.10.1053/euhj.2001.2892
16.
Udipi
,
K.
,
Chen
,
M.
,
Cheng
,
P.
,
Jiang
,
K.
,
Judd
,
D.
,
Caceres
,
A.
,
Melder
,
R. J.
, and
Wilcox
,
J. N.
,
2008
, “
Development of a Novel Biocompatible Polymer System for Extended Drug Release in a Next-Generation Drug-Eluting Stent
,”
J. Biomed. Mater. Res. Part A
,
85
(
4
), pp.
1064
1071
.10.1002/jbm.a.31664
17.
Steigerwald
,
K.
,
Merl
,
S.
,
Kastrati
,
A.
,
Wieczorek
,
A.
,
Vorpahl
,
M.
,
Mannhold
,
R.
,
Vogeser
,
M.
,
Hausleiter
,
J.
,
Joner
,
M.
,
Schömig
,
A.
, and
Wessely
,
R.
,
2009
, “
The Pre-Clinical Assessment of Rapamycin-Eluting, Durable Polymer-Free Stent Coating Concepts
,”
Biomaterials
30
(
4
), pp.
632
637
.10.1016/j.biomaterials.2008.10.005
18.
Gourlay
,
S. J.
,
Rice
,
R. M.
,
Hegyeli
,
A. F.
,
Wade
,
C. W.
,
Dillon
,
J. G.
,
Jaffe
,
H.
, and
Kulkarni
,
R. K.
,
1978
, “
Biocompatibility Testing of Polymers: In Vivo Implantation Studies
,”
J. Biomed. Mater. Res.
,
12
(
2
), pp.
219
232
.10.1002/jbm.820120207
19.
Jain
,
R. A.
,
2000
, “
The Manufacturing Techniques of Various Drug Loaded Biodegradable Poly(lactide-co-glycolide) (PLGA) Devices
,”
Biomaterials
,
21
(
23
), pp.
2475
2490
.10.1016/S0142-9612(00)00115-0
20.
Menke
,
H.
,
Grubmeyer
,
H.
,
Biemer
,
E.
, and
Olbrisch
,
R. R.
,
2001
, “
PVP Breast Implants After Two Years: Initial Results of a Prospective Study
,”
Aesthetic Plast. Surg.
,
25
(
4
), pp.
278
282
.10.1007/s002660010136
21.
Daemen
,
J.
, and
Serruys
.
P.
,
2007
, “
Drug Eluting Stent Update 2007—Part I: Survey of Current and Future Generation Drug-Eluting Stents: Meaningful Advances or More of the Same?,
Circulation
,
116
, pp.
316
328
.10.1161/CIRCULATIONAHA.106.621342
You do not currently have access to this content.